This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
(balanced Rearrangements Or Structural Markers Nec) Or (balanced Translocations)
Information about (balanced Rearrangements Or Structural Markers Nec) Or (balanced Translocations): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of (balanced Rearrangements Or Structural Markers Nec) Or (balanced Translocations)
Most recent studies have shown that (balanced Rearrangements Or Structural Markers Nec) Or (balanced Translocations) shares some biological mechanisms with acute-lymphocytic-leukemia, aneuploidy, chromosomal-translocation, chromosome-breakage, congenital-abnormality, cytogenetic-abnormality, down-syndrome, dysmyelopoietic-syndromes, leukemia, leukemia-myelocytic-acute, lymphoma, malignant-neoplasms, monosomy, myeloid-leukemia, neoplasms, trisomy.
Among the many pathways, these few ones have gauged particular interests from scientists studying (balanced Rearrangements Or Structural Markers Nec) Or (balanced Translocations), and have been seen in publications frequently: Aging, Brain Development, Cell Cycle, Cell Death, Cell Differentiation, Dna Repair, Fertilization, Interphase, Localization, Meiosis, Metaphase, Methylation, Mitotic Chromosome Condensation, Oncogenesis, Oogenesis, Palate Development, Pathogenesis, Prophase, Spermatogenesis, Transposition
Quite a number of genes have been found to play important roles in (balanced Rearrangements Or Structural Markers Nec) Or (balanced Translocations), such as ASXL1, BCR, CDK5R1, CDKN1A, CDKN2A, CDKN2B, CHP1, INVS, LMLN, MRPL28, NXT1, PAFAH1B1, PGD, PHGDH, RUNX1, SF3B1, SUB1, TP53, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.